Annual Cash & Cash Equivalents
$51.16 M
-$7.18 M-12.30%
31 December 2023
Summary:
Caribou Biosciences annual cash & cash equivalents is currently $51.16 million, with the most recent change of -$7.18 million (-12.30%) on 31 December 2023. During the last 3 years, it has risen by +$35.21 million (+220.70%). CRBU annual cash & cash equivalents is now -78.72% below its all-time high of $240.42 million, reached on 31 December 2021.CRBU Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$31.97 M
-$5.90 M-15.57%
30 September 2024
Summary:
Caribou Biosciences quarterly cash and cash equivalents is currently $31.97 million, with the most recent change of -$5.90 million (-15.57%) on 30 September 2024. Over the past year, it has dropped by -$72.09 million (-69.28%). CRBU quarterly cash and cash equivalents is now -92.66% below its all-time high of $435.31 million, reached on 30 September 2021.CRBU Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBU Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | -69.3% |
| 3 y3 years | +220.7% | -92.7% |
| 5 y5 years | - | - |
CRBU Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.7% | +220.7% | -92.7% | at low |
| 5 y | 5 years | -78.7% | +220.7% | -92.7% | +100.4% |
| alltime | all time | -78.7% | +220.7% | -92.7% | +100.4% |
Caribou Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.97 M(-15.6%) |
| June 2024 | - | $37.87 M(-23.3%) |
| Mar 2024 | - | $49.40 M(-3.4%) |
| Dec 2023 | $51.16 M(-12.3%) | $51.16 M(-50.8%) |
| Sept 2023 | - | $104.06 M(+57.2%) |
| June 2023 | - | $66.19 M(+25.5%) |
| Mar 2023 | - | $52.74 M(-9.6%) |
| Dec 2022 | $58.34 M | $58.34 M(-28.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $82.08 M(-26.8%) |
| June 2022 | - | $112.15 M(-24.0%) |
| Mar 2022 | - | $147.63 M(-38.6%) |
| Dec 2021 | $240.42 M(+1407.1%) | $240.42 M(-44.8%) |
| Sept 2021 | - | $435.31 M(+236.1%) |
| June 2021 | - | $129.52 M(-11.2%) |
| Mar 2021 | - | $145.92 M(+814.7%) |
| Dec 2020 | $15.95 M(-61.2%) | $15.95 M |
| Dec 2019 | $41.07 M | - |
FAQ
- What is Caribou Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Caribou Biosciences?
- What is Caribou Biosciences annual cash & cash equivalents year-on-year change?
- What is Caribou Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Caribou Biosciences?
- What is Caribou Biosciences quarterly cash and cash equivalents year-on-year change?
What is Caribou Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CRBU is $51.16 M
What is the all time high annual cash & cash equivalents for Caribou Biosciences?
Caribou Biosciences all-time high annual cash & cash equivalents is $240.42 M
What is Caribou Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, CRBU annual cash & cash equivalents has changed by -$7.18 M (-12.30%)
What is Caribou Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRBU is $31.97 M
What is the all time high quarterly cash and cash equivalents for Caribou Biosciences?
Caribou Biosciences all-time high quarterly cash and cash equivalents is $435.31 M
What is Caribou Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CRBU quarterly cash and cash equivalents has changed by -$72.09 M (-69.28%)